Evidence map›Paper›PMID 42453884›Full record

ArticleFrontiers in oncology2026

Long term survival of patients with alpha-fetoprotein-positive hepatoid adenocarcinoma of the gallbladder: a case report and literature review.

Fangzhou Wang, Xiang Gao, Wei Gao, Jie Cai, Yamin Zheng

Abstract readCase Reports
In one paragraph

Article in Frontiers in oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Fangzhou WangDepartment of General Surgery, Xuanwu Hospital, Capital Medical University, Beijing, China.
Xiang GaoDepartment of General Surgery, Xuanwu Hospital, Capital Medical University, Beijing, China.
Wei GaoDepartment of Pathology, Xuanwu Hospital, Capital Medical University, Beijing, China.
Jie CaiHealth Management Department, Xuanwu Hospital, Capital Medical University, Beijing, China.
Yamin ZhengDepartment of General Surgery, Xuanwu Hospital, Capital Medical University, Beijing, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hepatoid adenocarcinoma (HAC) of the gallbladder is an exceedingly rare and highly aggressive variant of gallbladder carcinoma that is frequently associated with alpha-fetoprotein (AFP) production and typically has a poor prognosis. We report a 66-year-old male with a two-week history of right upper abdominal pain. Imaging revealed a hypermetabolic mass at the gallbladder fundus, accompanied by a significantly elevated serum AFP concentration of 1210.00 ng/mL. Histopathological and immunohistochemical analyses confirmed a diagnosis of AFP-positive HAC. Notably, next-generation sequencing (NGS) revealed a

Indexed as

AFPcase reportgallbladdergallbladder carcinomahepatoid adenocarcinoma

Identifiers

PMID42453884
PMCPMC13364591

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.